Order byBest matchMost fresh
FDA Warns of Heart Risk With Pfizer, Moderna COVID Vaccines
The updated warnings highlight a rare risk of heart inflammation in teen boys and young men, CBS News reported. The warning applies to males ages 16 to 25 and is based on new data from FDA safety monitoring and a 2023 study. This includes both Pfizer's Comirnaty and Moderna's Spikevax vaccines.
FDA panel says Covid vaccines can stay the same for fall amid access concerns
Complicating matters, however, were new FDA rules for the updated Covid vaccines, announced just days earlier, that would restrict access of the shots to only the most at-risk Ame
FDA panel debates COVID vaccine recipe as questions swirl about fall shots
Government advisers are meeting Thursday to decide if COVID-19 vaccines need updating to improve protection this fall and winter — even as a new Trump administration policy has thrown into
FDA requires Covid vaccine makers to expand warning about risk of rare heart inflammation
The US Food and Drug Administration will now require Covid-19 vaccines from Pfizer/BioNTech and Moderna to use expanded warning labels with more information about the risk of a rare heart condition after vaccination.
FDA won’t approve COVID shot for healthy, non-elderly population
The Food and Drug Administration will no longer approve COVID-19 vaccines for healthy people under 65 without rigorous trials.
Explore more
The New Rational FDA COVID Vaccine Policy is Long Overdue, Says NanoViricides’ Dr. Diwan
SHELTON, CT / ACCESS Newswire / May 22, 2025 / Dr. Anil Diwan, President of NanoViricides, Inc. (NYSE Amer.:NNVC ) (the “Company”), comments on the new COVID Vaccine policy adopted by the US FDA. The new FDA COVID Vaccine Booster Shots policy [1] is based on the findings that the groups that benefit from repeat
Who can get updated COVID vaccines this fall? FDA will OK for high-risk groups, calls for new clinical trials
The Food and Drug Administration says it has decided to continue approving COVID-19 vaccine updates for seniors and others at higher risk of severe disease, but will require vaccine makers to conduct major new clinical trials before approving them for wider use.
FDA plans to limit COVID vaccine to only high-risk people: What Oklahomans should know
FDA leaders say the agency will require more clinical trials to show the benefits of annual COVID shots for healthy adults.
FDA sets new requirements for COVID vaccines in healthy adults and children
Federal health officials will no longer routinely approve annual COVID-19 shots for younger adults and children who are healthy
FDA to limit covid shot approval to 65+, those with medical conditions
The FDA will narrow its approval for updated coronavirus vaccines, marking a significant shift in the agency’s approach to green-lighting shots that have been recommended broadly to the public.
FDA may limit future Covid-19 shots to older people and those at risk of serious infection
The US Food and Drug Administration is changing the way it approves Covid-19 vaccines for Americans, a move that may limit future shots to older Americans and people at higher risk of serious Covid-19 infection.
COVID shots should target newer strains of JN.1 variant in 2025-26 campaign, US FDA advisers say
U.S. Food and Drug Administration advisers unanimously recommended on Thursday that COVID-19 vaccines for the 2025-26 period should target newer strains of the JN.1 variant. According to the Centers for Disease Control and Prevention,
Feedback